Cargando…
Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
[Image: see text] Since loss of function mutations of PINK1 lead to early onset Parkinson’s disease, there has been growing interest in the discovery of small molecules that amplify the kinase activity of PINK1. We herein report the design, synthesis, serum stability, and hydrolysis of four kinetin...
Autores principales: | Osgerby, Laura, Lai, Yu-Chiang, Thornton, Peter J., Amalfitano, Joseph, Le Duff, Cécile S., Jabeen, Iqra, Kadri, Hachemi, Miccoli, Ageo, Tucker, James H. R., Muqit, Miratul M. K., Mehellou, Youcef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410652/ https://www.ncbi.nlm.nih.gov/pubmed/28323427 http://dx.doi.org/10.1021/acs.jmedchem.6b01897 |
Ejemplares similares
-
The ProTide Prodrug
Technology: From the Concept to
the Clinic: Miniperspective
por: Mehellou, Youcef, et al.
Publicado: (2017) -
The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1
por: Barini, Erica, et al.
Publicado: (2018) -
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
por: Slusarczyk, Magdalena, et al.
Publicado: (2018) -
ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018) -
Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin
por: Derudas, Marco, et al.
Publicado: (2010)